TRMED — Thor Medical ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK1.58bn
- NOK1.57bn
- NOK0.44m
Annual cashflow statement for Thor Medical ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -440 | -310 | -5.56 | -42.6 | -62.3 |
| Depreciation | |||||
| Non-Cash Items | 3.96 | -11.8 | -28.2 | 1.11 | -2.62 |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 21.3 | -98.1 | -31.1 | 15.2 | -3.57 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -403 | -409 | -64.1 | -24 | -47.5 |
| Capital Expenditures | -0.259 | -5.63 | — | -0.14 | -73.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.12 | 3.16 | 6.28 | 1.7 | 6.63 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.863 | -2.46 | 6.28 | 1.56 | -66.5 |
| Financing Cash Flow Items | -28 | -17.2 | -0.32 | -9.82 | -9.19 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 385 | 228 | -0.332 | 104 | 171 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -16.3 | -179 | -56.9 | 81.6 | 57.2 |